In vitro evaluation of combination effects of doxorubicin with methylxanthine fractions isolated from Bancha and Pu-erh teas against breast cancer cells
Keywords:Pu-erh, Bancha, Methylxanthine, Breast cancer, Combination effect, Synergism
Background: In the present study we investigated the combination effects of anthracycline antibiotic, doxorubicin, with methylxanthine fractions isolated from Bancha and Pu-erh tea leaves, against MCF-7 and MDA-MB-231 breast cancer cell lines.
Methods: Neutral red uptake assay was used for assessment of cytotoxicity effects and fractional effect analysis and combination index for evaluation of the combination effects.
Results: Doxorubicin was used in varying concentrations by a double dilution method, whereas the methylxanthine fractions were in fixed concentrations – 100, 200, 400 or 600 μg/ml. Results have shown that methylxanthine fraction isolated from Bancha has synergic effects with doxorubicin, while methylxanthines from Pu-erh displayed antagonistic effects.
Conclusions: Тhe obtained results lead us to suspect, that even minor differences in the composition of natural products can lead to significant differences in the biological activity of the product.
Nehlig A, Daval Jl Fau - Debry G, Debry G. Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects. Brain Res Brain Res Rev. 1992;17(2):139-70.
Fredholm BB, Bättig K, Holmén J, Nehlig A, Zvartau EE. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev. 1999;51(1):83-133.
Georgiev K, Zhelev I, Georgieva S. Total phenolic compounds and tannins content of Bancha green tea (Camellia Sinensis) depending on extraction conditions. Scripta Scientifica Pharmaceutica. 2014;1(1):48-51.
Verrill M. Anthracyclines in breast cancer: therapy and issues of toxicity. The Breast. 2001;10(2):8-15.
Lee JH, Nan A. Combination Drug Delivery Approaches in Metastatic Breast Cancer. J Drug Delivery. 2012;2012:915375.
Georgiev K, Iliev I, Jelev I. Evaluation of antitumor effect of methylxanthine fraction isolated from Pu-erh tea. WJPR. 2015;4(7):2236-42.
Borenfreund E, Puerner JA. A simple quantitative procedure using monolayer culture for toxicity assays. J. Tissue Cult. Meth. 1984;9:7-9.
Bliss CI. The toxicity of poisons applied jointly. Ann Appl Biol. 1939;26:585-615.
Webb JL. Enzyme and Metabolic Inhibitors. New York: Academic Press; 1963: 55-79.
Chou TC. Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res. 2010;70:440-6.
Chou TC, Hayball MP. CalcuSyn for Windows: multiple-drug dose-effect analyzer and manual. Cambridge (UK): Biosoft; 1997.
Pezzani R, Salehi B, Vitalini S, Iriti M, Zuñiga FA, Sharifi-Rad J, et al. Synergistic Effects of Plant Derivatives and Conventional Chemotherapeutic Agents: An Update on the Cancer Perspective. Medicina (Kaunas). 2019;55(4):110.
Verster JC, Koenig J. Caffeine intake and its sources: A review of national representative studies. Crit Rev Food Sci Nutr. 2018;58(8):1250-9.
Selby CP, Sancar A. Molecular mechanisms of DNA repair inhibition by caffeine. Proc Natl Acad Sci U S A. 1990;87(9):3522-5.
Iliakis G, Nusse M, Ganapathi R, Egner J, Yen A. Differential reduction by caffeine of adriamycin induced cell killing and cell cycle delays in Chinese hamster V79 cells. Int J Radiation Oncol Biol Physics. 1986;12:1987-95.
Kakuyama (nee Iwazaki) A, Sadzuka Y. Effect of Methylxanthine Derivatives on Doxorubicin Transport and Antitumor Activity. Current Drug Metabol. 2001;2(4):379-95.
Sadzuka Y, Mochizuki E, Takino Y. Mechanism of caffeine modulation of the antitumor activity of adriamycin. Toxicol Lett. 1995;75(1-3):39-49.
Traganos F, Kapuscinski J, Darzynkiewicz Z. Caffeine modulates the effects of DNA-intercalating drugs in vitro: a flow cytometric and spectrophotometric analysis of caffeine interaction with novantrone, doxorubicin, ellipticine, and the doxorubicin analogue AD198. Cancer Res. 1991;51(14):3682-9.
Traganos F, Kaminska-Eddy B, Darzynkiewicz Z. Caffeine reverses the cytotoxic and cell kinetic effects of Novantrone (mitoxantrone). Cell Prolif. 1991;24(3):305-19.
Piosik J, Gwizdek-Wiśniewska A, Ulanowska K, Ochociński J, Czyz A, Wegrzyn G. Methylxanthines (caffeine, pentoxifylline and theophylline) decrease the mutagenic effect of daunomycin, doxorubicin and mitoxantrone. Acta Biochim Pol. 2005;52(4):923-6.
Nahon E, Best-Belpomme M, Saucier JM. Analysis of the DNA topoisomerase-II-mediated cleavage of the long terminal repeat of Drosophila 1731 retrotransposon. Eur J Biochem. 1993;218(1):95-102.
Kimura H, Aoyama T. Decrease in sensitivity to ethidium bromide by caffeine, dimethylsulfoxide or 3-aminobenzamide due to reduced permeability. J Pharmacobiodynamics. 1989;12(10):589-95.
Martins IL, Miranda JP, Oliveira NG, Fernandes AS, Gonçalves S, Antunes AM. Synthesis and biological activity of 6-selenocaffeine: potential modulator of chemotherapeutic drugs in breast cancer cells. Molecules. 2013;18(5):5251-64.
Hertz E, Cadoná FC, Machado AK, Azzolin V, Holmrich S, Assmann C, Ledur P, Ribeiro EE, DE Souza Filho OC, Mânica-Cattani MF, DA Cruz IB. Effect of Paullinia cupana on MCF-7 breast cancer cell response to chemotherapeutic drugs. Mol Clin Oncol. 2015;3(1):37-43.
Hill GM, Moriarity DM, Setzer WN. Attenuation of cytotoxic natural product DNA intercalating agents by caffeine. Sci Pharm. 2011;79(4):729-47.